Cargando…
Breast cancer cells mediate endothelial cell activation, promoting von Willebrand factor release, tumor adhesion, and transendothelial migration
BACKGROUND: Breast cancer results in a three‐ to four‐fold increased risk of venous thromboembolism (VTE), which is associated with reduced patient survival. Despite this, the mechanisms underpinning breast cancer‐associated thrombosis remain poorly defined. Tumor cells can trigger endothelial cell...
Autores principales: | Dhami, Sukhraj Pal Singh, Patmore, Sean, Comerford, Claire, Byrne, Ciara M., Cavanagh, Brenton, Castle, John, Kirwan, Cliona C., Kenny, Martin, Schoen, Ingmar, O'Donnell, James S., O'Sullivan, Jamie M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796425/ https://www.ncbi.nlm.nih.gov/pubmed/35722954 http://dx.doi.org/10.1111/jth.15794 |
Ejemplares similares
-
Potent and rapid reversal of the von Willebrand factor inhibitor aptamer BT200
por: Zhu, Shuhao, et al.
Publicado: (2020) -
The development and characterization of a long acting anti‐thrombotic von Willebrand factor (VWF) aptamer
por: Zhu, Shuhao, et al.
Publicado: (2020) -
Identification of cysteine thiol‐based linkages in ADAMTS13 in support of a non‐proteolytic regulation of von Willebrand factor
por: Rottensteiner, Hanspeter, et al.
Publicado: (2019) -
von Willebrand factor links primary hemostasis to innate immunity
por: Drakeford, Clive, et al.
Publicado: (2022) -
Phase 3 study of recombinant von Willebrand factor in patients with severe von Willebrand disease who are undergoing elective surgery
por: Peyvandi, F., et al.
Publicado: (2018)